Bayer has Q and full-year 2022 data due Feb. 28. Goldman Sachs analysts don’t expect any big surprises based on the numbers. An agreement should be reached on both sales and adjusted operating profit. The market expects a profit of 7.82 euros per share. -Analysts reaffirm their buy recommendation on shares of Bayer (WKN: BAY001, ISIN: DE000BAY0017, chart). The target price is still 82.00 EUR. The forecast of the DAX group for 2023 is important. With the new CEO, Bill Anderson, there should be some changes. He will start work on June 1. , Bayer shares fell 0.6 percent to 59.08 euros in the afternoon.